BEIJING, June 16 (Reuters) – Novo Nordisk plans to seek Chinese regulatory approval for its Wegovy weight-loss pill "very soon," its CEO said on Tuesday, as it moves to catch up with rival Eli Lilly
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Alex Marquez takes Sepang pole as injured Martin withdraws from Malaysian GP
VIDEO SHOWS: ACTION FROM THE MALAYSIAN GRAND PRIX QUALIFYING - THE 19TH ROUND OF THE…
UPDATE 1-Motorcycling-Acosta wins Malaysian GP sprint, Marc Marquez extends championship lead
* Pedro Acosta wins second sprint of season in Sepang * Marc Marquez finishes second,…
Cathay Pacific says Amadeus breach affected 53,000 bookings
Oct 30 (Reuters) - Hong Kong flagship carrier Cathay Pacific Airways said on Friday a…
